Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105622537A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105622537A details a Lewis base-catalyzed route for isoxazoles, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105622537A reveals a metal-free synthesis for 3,4,5-trisubstituted isoxazoles. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.